La Jolla Pharmaceutical 2025 Company Profile: Valuation ...
Jul 28, 2014 · Information on acquisition, funding, cap tables, investors, and executives for La Jolla Pharmaceutical. Use the PitchBook Platform to explore the full profile.
La Jolla Pharmaceutical Company to Acquire Tetraphase
Jun 24, 2020 · La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc. June 24, 2020 07:30 ET | Source: La Jolla Pharmaceutical Company; Tetraphase Pharmaceuticals, Inc. Follow
La Jolla Pharmaceutical Company Announces the Closing of
Jul 28, 2020 · La Jolla Pharmaceutical Company Announces the Closing of Acquisition of Tetraphase Pharmaceuticals, Inc.
Innoviva enters agreement to acquire La Jolla Pharmaceutical ...
Jul 11, 2022 · La Jolla focuses on marketing innovative treatments that can enhance outcomes in patients with life-threatening diseases. Credit: National Cancer Institute on Unsplash. Innoviva has …
Innoviva builds in infectious diseases with La Jolla Pharma buy
4 days ago · La Jolla Pharmaceuticals' dreams of building a lucrative business from its stable of drugs used in infectious diseases never really paid off, and the company has now sold itself to royalty and ...
Innoviva Launches Innoviva Specialty Therapeutics to Deliver ...
May 9, 2023 · Innoviva Specialty Therapeutics integrates Entasis Therapeutics Holdings Inc. (Entasis), a pioneer in the development of novel, anti-infective therapies, and La Jolla Pharmaceutical Company …
Innoviva to Acquire La Jolla Pharmaceutical Company
Jul 11, 2022 · Innoviva to Acquire La Jolla Pharmaceutical Company Acquisition to strengthen Innoviva’s infectious disease and hospital portfolio with addition of GIAPREZA ® and XERAVA ®
Innoviva Completes Acquisition of La Jolla Pharmaceutical
Aug 22, 2022 · As a result of the acquisition, La Jolla became a wholly-owned subsidiary of Innoviva and the company’s common stock will be delisted from the Nasdaq Global Market.